US Patent Issued to Tarsus Pharmaceuticals on June 23 for "Methods for treating ocular Demodex using spinosad formulations" (California, Nevada Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,339, issued on June 23, was assigned to Tarsus Pharmaceuticals Inc. (Irvine, Calif.).

"Methods for treating ocular Demodex using spinosad formulations" was invented by Bobak Robert Azamian (Newport Coast, Calif.), Douglas Michael Ackermann (Reno, Nev.), Shawn D. Hickok (Aliso Viejo, Calif.) and Joseph G. Vehige (Irvine, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis. The methods can include topically administering directly to an ocular surface of one or more eyes of a patient in n...